Expression of platelet-derived growth factor β receptor in atrial tissue during atrial fibrillation of dogs
Guo Linna
Abstract
Guo Linna
Abstract
Aim:To detect the expression and the effects of PDGFR-β on myocardial remodeling during atrial fibrillation.Methods:Ten dogs underwent continuous rapid atrial pacing(500 beats/min)to create persistent atrial fibrillation.In five rapidly-paced dogs,mibefradil dihydrochloride was given beginning 2 days after pacemaker implantation,continuing until the twenty-fourth week.A group of size-match dogs(n=5)without given mibefradil was used as pure atrial fibrillation group.Another group of size-matched dogs(n=5)without pacemaker implantation was used as control group.RT-PCR was used to detect the expression of PDGFR-β mRNA.Immunohistochemistry was used to detect the expressions of PDGFR-β and cardiac collagen subtype Ⅲ.Van-Gieson(V-G)method was used to detect total cardiac collagen.Results:The expressions of PDGFR-β mRNA in atrial tissue were different among the 3 groups(F=10.017,P=0.004),which was lower in mibefradil group than that of atrial fibrillation group(P0.05).The expressions of PDGFR-β,cardiac collagen subtype Ⅲ,and total cardiac collagen in atrial tissue were different among the 3 groups(F=111.015,39.358,and 174.805,P0.001),which was different between each 2 groups(P0.05).Conclusion:There is fibrosis in atrial myocyte during atrial fibrillation,which is not associated with PDGFR-β signaling pathway.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Aim:To detect the expression and the effects of PDGFR-β on myocardial remodeling during atrial fibrillation.Methods:Ten dogs underwent continuous rapid atrial pacing(500 beats/min)to create persistent atrial fibrillation.In five rapidly-paced dogs,mibefradil dihydrochloride was given beginning 2 days after pacemaker implantation,continuing until the twenty-fourth week.A group of size-match dogs(n=5)without given mibefradil was used as pure atrial fibrillation group.Another group of size-matched dogs(n=5)without pacemaker implantation was used as control group.RT-PCR was used to detect the expression of PDGFR-β mRNA.Immunohistochemistry was used to detect the expressions of PDGFR-β and cardiac collagen subtype Ⅲ.Van-Gieson(V-G)method was used to detect total cardiac collagen.Results:The expressions of PDGFR-β mRNA in atrial tissue were different among the 3 groups(F=10.017,P=0.004),which was lower in mibefradil group than that of atrial fibrillation group(P0.05).The expressions of PDGFR-β,cardiac collagen subtype Ⅲ,and total cardiac collagen in atrial tissue were different among the 3 groups(F=111.015,39.358,and 174.805,P0.001),which was different between each 2 groups(P0.05).Conclusion:There is fibrosis in atrial myocyte during atrial fibrillation,which is not associated with PDGFR-β signaling pathway.
Key concepts: Atrial fibrillation, Internal medicine, Medicine, Mibefradil, Cardiology, Receptor, Antagonist